Autolus Therapeutics Plc (AUTL)
2.345
-0.06
(-2.70%)
USD |
NASDAQ |
Aug 24, 16:00
2.34
0.00 (0.00%)
After-Hours: 20:00
Autolus Therapeutics Total Liabilities (Quarterly) : 418.39M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 418.39M |
| March 31, 2026 | 418.24M |
| December 31, 2025 | 410.94M |
| September 30, 2025 | 396.50M |
| June 30, 2025 | 374.52M |
| March 31, 2025 | 375.23M |
| December 31, 2024 | 355.40M |
| September 30, 2024 | 350.52M |
| June 30, 2024 | 325.78M |
| March 31, 2024 | 319.41M |
| December 31, 2023 | 263.91M |
| September 30, 2023 | 225.58M |
| June 30, 2023 | 221.66M |
| March 31, 2023 | 193.05M |
| December 31, 2022 | 191.60M |
| Date | Value |
|---|---|
| September 30, 2022 | 102.68M |
| June 30, 2022 | 99.46M |
| March 31, 2022 | 92.85M |
| December 31, 2021 | 92.24M |
| September 30, 2021 | 51.91M |
| June 30, 2021 | 46.97M |
| March 31, 2021 | 50.18M |
| December 31, 2020 | 84.20M |
| September 30, 2020 | 80.27M |
| June 30, 2020 | 51.60M |
| March 31, 2020 | 50.19M |
| December 31, 2019 | 48.69M |
| September 30, 2019 | 45.00M |
| June 30, 2019 | 47.92M |
| March 31, 2019 | 46.47M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Bicycle Therapeutics Plc | 96.32M |
| Biodexa Pharmaceuticals Plc | -- |
| argenx SE | -- |
| Mereo BioPharma Group Plc | 6.062M |
| Evaxion AS | 9.849M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 493.23M |
| Shareholders Equity (Quarterly) | 74.84M |
| Debt to Equity Ratio | 4.915 |
| Current Ratio | 4.847 |
| Net Debt Paydown Yield | -2.66% |